485 related articles for article (PubMed ID: 20591908)
21. Leucocyte-specific protein (LSP1) in malignant lymphoma and Hodgkin's disease.
Marafioti T; Jabri L; Pulford K; Brousset P; Mason DY; Delsol G
Br J Haematol; 2003 Feb; 120(4):671-8. PubMed ID: 12588355
[TBL] [Abstract][Full Text] [Related]
22. [Lymphoid depletion type 4 Hodgkin disease. Anatomoclinical review of 35 cases].
Eghbali H; Pétorin C; de Mascarel I; Trojani M; Hoerni-Simon G; Soubeyran P; Hoerni B
Bull Cancer; 1994 Oct; 81(10):866-70. PubMed ID: 7734769
[TBL] [Abstract][Full Text] [Related]
23. Cytokine production (IL-1 alpha, IL-1 beta, and TNF alpha) and endothelial cell activation (ELAM-1 and HLA-DR) in reactive lymphadenitis, Hodgkin's disease, and in non-Hodgkin's lymphomas. An immunocytochemical study.
Ruco LP; Pomponi D; Pigott R; Stoppacciaro A; Monardo F; Uccini S; Boraschi D; Tagliabue A; Santoni A; Dejana E
Am J Pathol; 1990 Nov; 137(5):1163-71. PubMed ID: 1700619
[TBL] [Abstract][Full Text] [Related]
24. Neuron-specific enolase (gamma enolase, gamma-gamma dimer) expression in Hodgkin's disease and large cell lymphomas.
Massarelli G; Onida GA; Piras MA; Marras V; Mura A; Tanda F
Anticancer Res; 1999; 19(5B):3933-8. PubMed ID: 10628334
[TBL] [Abstract][Full Text] [Related]
25. [The relations between Hodgkin's and non-Hodgkin's lymphoma].
Lennert K
Arzneimittelforschung; 1987 Feb; 37(2A):255-9. PubMed ID: 3566873
[TBL] [Abstract][Full Text] [Related]
26. Longer failure-free survival interval of Epstein-Barr virus-associated classical Hodgkin's lymphoma: a single-institution study.
Krugmann J; Tzankov A; Gschwendtner A; Fischhofer M; Greil R; Fend F; Dirnhofer S
Mod Pathol; 2003 Jun; 16(6):566-73. PubMed ID: 12808062
[TBL] [Abstract][Full Text] [Related]
27. Use of LeuM1 monoclonal antibody for the diagnosis of Hodgkin's disease.
Memon GM; Alam SM
J Pak Med Assoc; 1990 Jul; 40(7):156-9. PubMed ID: 1980316
[TBL] [Abstract][Full Text] [Related]
28. CD40 expression in Hodgkin's disease.
O'Grady JT; Stewart S; Lowrey J; Howie SE; Krajewski AS
Am J Pathol; 1994 Jan; 144(1):21-6. PubMed ID: 7507299
[TBL] [Abstract][Full Text] [Related]
29. Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma.
Tzankov A; Meier C; Hirschmann P; Went P; Pileri SA; Dirnhofer S
Haematologica; 2008 Feb; 93(2):193-200. PubMed ID: 18223287
[TBL] [Abstract][Full Text] [Related]
30. Diagnostic difficulties of pure intrasinusoidal bone marrow infiltration of non-Hodgkin's lymphoma: a report of eight cases from India.
Das R; Sachdeva MU; Malhotra P; Das A; Ahluwalia J; Bal A; Jain S; Varma N; Varma S
Jpn J Clin Oncol; 2011 Nov; 41(11):1303-7. PubMed ID: 21940732
[TBL] [Abstract][Full Text] [Related]
31. CDK9/CYCLIN T1 expression during normal lymphoid differentiation and malignant transformation.
Bellan C; De Falco G; Lazzi S; Micheli P; Vicidomini S; Schürfeld K; Amato T; Palumbo A; Bagella L; Sabattini E; Bartolommei S; Hummel M; Pileri S; Tosi P; Leoncini L; Giordano A
J Pathol; 2004 Aug; 203(4):946-52. PubMed ID: 15258998
[TBL] [Abstract][Full Text] [Related]
32. Pathology and "molecular histology' of Hodgkin's disease and the border to non-Hodgkin's lymphomas.
Hansmann ML; Küppers R
Baillieres Clin Haematol; 1996 Sep; 9(3):459-77. PubMed ID: 8922240
[TBL] [Abstract][Full Text] [Related]
33. Primary non-hodgkin's lymphoma of bone: experience of a decade.
Qureshi A; Ali A; Riaz N; Pervez S
Indian J Pathol Microbiol; 2010; 53(2):267-70. PubMed ID: 20551530
[TBL] [Abstract][Full Text] [Related]
34. [Dipeptidyl aminopeptidase-IV as a histochemical marker of differential diagnosis of large cell anaplastic CD30+-lymphoma and Hodgkin's disease].
Raĭkhlin NT; Bukaeva IA; Probatova NA; Smirnova EA; Pavlovskaia AI; Tupitsyn NN; Sholokhova EN
Arkh Patol; 2000; 62(4):3-8. PubMed ID: 10971865
[TBL] [Abstract][Full Text] [Related]
35. The interrelationship of Hodgkin's disease and non-Hodgkin's lymphomas--lessons learned from composite and sequential malignancies.
Jaffe ES; Zarate-Osorno A; Medeiros LJ
Semin Diagn Pathol; 1992 Nov; 9(4):297-303. PubMed ID: 1480852
[TBL] [Abstract][Full Text] [Related]
36. Tissue flow cytometry immunophenotyping in the diagnosis and classification of non-Hodgkin's lymphomas: a retrospective evaluation of 1,792 cases.
Demurtas A; Stacchini A; Aliberti S; Chiusa L; Chiarle R; Novero D
Cytometry B Clin Cytom; 2013 Mar; 84(2):82-95. PubMed ID: 23325563
[TBL] [Abstract][Full Text] [Related]
37. Terminal deoxynucleotidyl transferase in diagnosis of lymphomas.
Rudzka E; Hołowiecki J; Bartnikowa W; Krawczyk M
Folia Haematol Int Mag Klin Morphol Blutforsch; 1989; 116(2):245-50. PubMed ID: 2475404
[TBL] [Abstract][Full Text] [Related]
38. Non-Hodgkin's lymphomas: an immunohistochemical and histological study.
Curran RC; Jones EL
J Pathol; 1979 Dec; 129(4):179-90. PubMed ID: 317105
[TBL] [Abstract][Full Text] [Related]
39. Immunohistochemical typing of non-Hodgkin's lymphoma-comparing working formulation and WHO classification.
Kalyan K; Basu D; Soundararaghavan J
Indian J Pathol Microbiol; 2006 Apr; 49(2):203-7. PubMed ID: 16933715
[TBL] [Abstract][Full Text] [Related]
40. Localization of proliferating cell nuclear antigen (PCNA/Cyclin) in workshop cases of Hodgkin's disease and non-Hodgkin's lymphoma.
Kamel OW; Warnke RA; Banks PM
Semin Diagn Pathol; 1992 Nov; 9(4):311-4. PubMed ID: 1362284
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
